Skip to main content
Bacterial: new drugs, duration of therapy, febrile neutropenia
Open 12 Users 38 Files
 TypeSizeDate
v Early Antimicrobial De-escalation and Stewardship OFID 17 Snyder.pdf
Dina Averbuch
189 KBsApr 8, 2024
Antimicrobial de-escalation in adult JOPP petteys 2019.pdf
Dina Averbuch
300 KBsApr 8, 2024
Safety of discharge for children with cancer and febrile Campbell_et_al-2018-Pediatric_Blood_%26_Cancer.pdf
Dina Averbuch
567 KBsApr 8, 2024
Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients Alali JPHO 23.pdf
Dina Averbuch
194 KBsApr 8, 2024
Evaluation of early discharge after hospital treatment of neutropenic Chow LRR 13.pdf
Dina Averbuch
171 KBsApr 8, 2024
Efficacy of antibiotic short course for bloodstream infections Metais JI 22.pdf
Dina Averbuch
1 MBApr 8, 2024
v Short Course of Antibiotic Therapy for Gram-Negative Bacilli Herrera microorganisms-2023.pdf
Dina Averbuch
1 MBApr 8, 2024
Evaluating antimicrobial duration for Gram-negative Transplant Infectious Dis - 2023 - Ranganath.pdf
Dina Averbuch
474 KBsApr 8, 2024
Is short-course antibiotic therapy suitable for Pseudomonas Feng CID 2023.pdf
Dina Averbuch
819 KBsApr 8, 2024
v Systematic Review of the Short-Term versus Long-Term Ishikawa Ca 23.pdf
Dina Averbuch
1 MBApr 8, 2024
s Early discontinuation of antibiotics for febrile neutropenia stern-2019-cochrane_database_of_systematic_reviews.pdf
Dina Averbuch
643 KBsApr 8, 2024
v Safety and Efficacy of Antibiotic De-escalation Verlinden OFID 22.pdf
Dina Averbuch
182 KBsApr 8, 2024
early-de-escalation-of-antibiotic-therapy-in-hospitalized-cellular-therapy-adult-patients-with-febrile-neutropenia Lucena Clin Hem Int 2024.pdf
Dina Averbuch
401 KBsApr 8, 2024
De-escalation And Discontinuation Martire2018_EJCMID 18 cordonnier.pdf
Dina Averbuch
1 MBApr 8, 2024
Efficacy of an antimicrobial stewardship Durand ARIC 2024.pdf
Dina Averbuch
2 MBsApr 8, 2024